27.40
price up icon5.73%   1.485
after-market Handel nachbörslich: 27.40
loading

Finanzdaten der Inhibrx Biosciences Inc-Aktie (INBX)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
100.00%
-
0.10 - 0.10 -
Operating Expenses
14.25%
42.90
50.03 46.80 161.00 73.83
Operating Income/Loss
14.07%
-42.90
-49.93 -46.80 -160.90 -73.83
Nonoperating Income/Loss
119.87%
-0.41
2.063 2.933 2,018.91 -4.885
Income/Loss From Continuing Operations Before Tax
9.51%
-43.31
-47.87 -43.86 1,858.01 -78.71
Income Tax Expense/Benefit
-
- - 0.002 -
Income/Loss From Continuing Operations After Tax
9.51%
-43.31
-47.87 -43.86 1,858.01 -78.71
Net Income/Loss
9.51%
-43.31
-47.87 -43.86 1,858.01 -78.71
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
6,805%
15.47
0.224 15.47 14.62 54.55
Diluted Average Shares
9,390%
15.47
0.163 15.47 14.81 54.55
Basic Earnings Per Share
44.33%
-2.80
-5.03 -2.84 127.10 -1.44
Diluted Earnings Per Share
37.36%
-2.80
-4.47 -2.84 125.48 -1.44
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$24.78
price up icon 0.98%
$84.84
price up icon 1.00%
$24.80
price down icon 8.06%
$103.01
price down icon 1.70%
$134.53
price up icon 1.79%
biotechnology ONC
$300.14
price down icon 2.84%
Kapitalisierung:     |  Volumen (24h):